Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity

Abstract

Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ transplant. Recent developments have raised the prospect of using rapamycin to treat cancer or diabetes and to delay aging. It is therefore important to asse.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,150

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

  • Only published works are available at libraries.

Similar books and articles

Endocrine effects on glucose and insulin periodicity.Larry L. Bellinger - 1981 - Behavioral and Brain Sciences 4 (4):576-576.

Analytics

Added to PP
2017-05-07

Downloads
1 (#1,903,274)

6 months
1 (#1,475,652)

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Author's Profile

David Young
University of Glasgow

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references